<VariationArchive VariationID="956069" VariationName="NM_005670.4(EPM2A):c.118del (p.Arg39_Leu40insTer)" VariationType="Deletion" Accession="VCV000956069" Version="6" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2020-07-16" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="944913" VariationID="956069">
      <GeneList>
        <Gene Symbol="EPM2A" FullName="EPM2A glucan phosphatase, laforin" GeneID="7957" HGNC_ID="HGNC:3413" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>6q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="145383353" stop="145736023" display_start="145383353" display_stop="145736023" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="145946439" stop="146056990" display_start="145946439" display_stop="146056990" Strand="-" />
          </Location>
          <OMIM>607566</OMIM>
        </Gene>
        <Gene Symbol="EPM2A-DT" FullName="EPM2A divergent transcript" GeneID="100507557" HGNC_ID="HGNC:48990" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>6q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="145734869" stop="145886585" display_start="145734869" display_stop="145886585" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129997381" FullName="ATAC-STARR-seq lymphoblastoid silent region 17642" GeneID="129997381" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>6q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="145734995" stop="145735584" display_start="145734995" display_stop="145735584" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_005670.4(EPM2A):c.118del (p.Arg39_Leu40insTer)</Name>
      <CanonicalSPDI>NC_000006.12:145735380:GG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="145735381" stop="145735381" display_start="145735381" display_stop="145735381" variantLength="1" positionVCF="145735380" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="146056517" stop="146056517" display_start="146056517" display_stop="146056517" variantLength="1" positionVCF="146056516" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.146056518del" Assembly="GRCh37">
            <Expression>NC_000006.11:g.146056518del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.145735382del" Assembly="GRCh38">
            <Expression>NC_000006.12:g.145735382del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012832.2" sequenceAccession="NG_012832" sequenceVersion="2" change="g.5475del">
            <Expression>NG_012832.2:g.5475del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001018041.2" sequenceAccession="NM_001018041" sequenceVersion="2" change="c.118del">
            <Expression>NM_001018041.2:c.118del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001018051.1" sequenceAccession="NP_001018051" sequenceVersion="1" change="p.Arg39_Leu40insTer">
            <Expression>NP_001018051.1:p.Arg39_Leu40insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001360057.2" sequenceAccession="NM_001360057" sequenceVersion="2" change="c.118del">
            <Expression>NM_001360057.2:c.118del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001346986.1" sequenceAccession="NP_001346986" sequenceVersion="1" change="p.Arg39_Leu40insTer">
            <Expression>NP_001346986.1:p.Arg39_Leu40insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001360071.2" sequenceAccession="NM_001360071" sequenceVersion="2" change="c.-552del">
            <Expression>NM_001360071.2:c.-552del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368129.2" sequenceAccession="NM_001368129" sequenceVersion="2" change="c.-506del">
            <Expression>NM_001368129.2:c.-506del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368130.1" sequenceAccession="NM_001368130" sequenceVersion="1" change="c.118del">
            <Expression>NM_001368130.1:c.118del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001355059.1" sequenceAccession="NP_001355059" sequenceVersion="1" change="p.Arg39_Leu40insTer">
            <Expression>NP_001355059.1:p.Arg39_Leu40insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368131.1" sequenceAccession="NM_001368131" sequenceVersion="1" change="c.-250del">
            <Expression>NM_001368131.1:c.-250del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005670.4" sequenceAccession="NM_005670" sequenceVersion="4" change="c.118del" MANESelect="true">
            <Expression>NM_005670.4:c.118del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005661.1" sequenceAccession="NP_005661" sequenceVersion="1" change="p.Arg39_Leu40insTer">
            <Expression>NP_005661.1:p.Arg39_Leu40insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001360064.2" sequenceAccession="NM_001360064" sequenceVersion="2" change="c.-114+527del">
            <Expression>NM_001360064.2:c.-114+527del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1170939620" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005670.4(EPM2A):c.118del (p.Arg39_Leu40insTer) AND Progressive myoclonic epilepsy" Accession="RCV001228808" Version="5">
        <ClassifiedConditionList TraitSetID="13597">
          <ClassifiedCondition DB="MedGen" ID="C0751778">Progressive myoclonic epilepsy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-08-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005670.4(EPM2A):c.118del (p.Arg39_Leu40insTer) AND not provided" Accession="RCV003234007" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-18" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-05-18" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-07-16" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20738377</ID>
        </Citation>
        <DescriptionHistory Dated="2023-06-14">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="13597" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3141" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Myoclonic Epilepsies, Progressive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myoclonus epilepsy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Progressive myoclonus epilepsy</ElementValue>
                <XRef ID="MONDO:0020074" DB="MONDO" />
                <XRef ID="267581004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial progressive myoclonic epilepsy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Progressive myoclonic epilepsy</ElementValue>
                <XRef ID="Progressive+myoclonic+epilepsy/9622" DB="Genetic Alliance" />
                <XRef ID="267581004" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7140" />
                <XRef ID="7140" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="NICE, 2022">
                <URL>https://www.nice.org.uk/guidance/ng217</URL>
                <CitationText>UK NICE Guideline NG217, Epilepsies in children, young people and adults, 2022</CitationText>
              </Citation>
              <XRef ID="308" DB="Orphanet" />
              <XRef ID="98261" DB="Orphanet" />
              <XRef ID="C0751778" DB="MedGen" />
              <XRef ID="MONDO:0020074" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS254800" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7348383" SubmissionDate="2023-06-14" DateLastUpdated="2023-06-17" DateCreated="2023-06-17">
        <ClinVarSubmissionID localKey="GDXSV:274758" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV003930496" DateUpdated="2023-06-17" DateCreated="2023-06-17" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EPM2A" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:5214906</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005670.3:c.118del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_197_20230614054203</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2736219" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="7255804|MedGen:C0751778" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001401226" DateUpdated="2024-02-20" DateCreated="2020-07-16" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-08-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20738377</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Leu40*) in the EPM2A gene. It is expected to result in an absent or disrupted protein product. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database. This variant has not been reported in the literature in individuals with EPM2A-related conditions. Loss-of-function variants in EPM2A are known to be pathogenic (PMID: 20738377). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EPM2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.146056517del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0751778" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2736219" TraitType="Disease" MappingType="XRef" MappingValue="C0751778" MappingRef="MedGen">
        <MedGen CUI="C0751778" Name="Progressive myoclonic epilepsy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7348383" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>